Today’s R&D is brought to you by Prepd (pronounced “prepped”). Prepd is building debate technology that helps extempers and congressional debaters research, practice, and compete. Visit www.prepd.in to learn more.
This week’s R&D covers the omicron variant of COVID-19. First discovered in South Africa, the variant is still under study and as of the time of this R&D’s creation, a handful of cases have been identified in the United States. There are fears that the new variant might infected vaccinated individuals and be more contagious than the delta variant from India.
As the omicron variant stirs concerns across the globe, the CDC says all American adults who have been vaccinated against COVID-19 should get a booster shot. https://t.co/bwuKaSZMaG
— U.S. News & World Report (@usnews) December 2, 2021
The possibility that Omicron might now outcompete Delta has the world on edge and may yet see markets lose their cool. We explain how wildly it differs from other variants https://t.co/KZFM8lNm7P
— The Economist (@TheEconomist) December 2, 2021
Biden says his top experts anticipate COVID-19 cases to increase in the weeks and months ahead as the omicron variant is likely to spread throughout the United States this winter. https://t.co/XiYLK6DWTj
— Roll Call (@rollcall) December 2, 2021